Skip to main content

Advertisement

ADVERTISEMENT

Blogs

Blog
09/04/2024
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
This is a continuation of our...
09/04/2024
First Report Managed Care
Blog
08/28/2024
FDA eases biosimilar interchangeability rules, dropping switching studies. New guidance and legislation aim to boost access and lower costs.
FDA eases biosimilar interchangeability rules, dropping switching studies. New guidance and legislation aim to boost access and lower costs.
FDA eases biosimilar...
08/28/2024
First Report Managed Care
Blog
08/21/2024
The SMART Prices Act aims to strengthen Medicare drug pricing reforms but faces opposition from manufacturers and uncertain prospects in Congress.
The SMART Prices Act aims to strengthen Medicare drug pricing reforms but faces opposition from manufacturers and uncertain prospects in Congress.
The SMART Prices Act aims to...
08/21/2024
First Report Managed Care

Advertisement

Blog
08/14/2024
CMS’s new IPPS rule aims to bolster small hospitals’ buffer stocks of drug shortages, aligning with HHS’s broader strategy.
CMS’s new IPPS rule aims to bolster small hospitals’ buffer stocks of drug shortages, aligning with HHS’s broader strategy.
CMS’s new IPPS rule aims to...
08/14/2024
First Report Managed Care
Blog
08/07/2024
Supreme Court overturns Chevron: what it means for FDA power, drug laws, and public health.
Supreme Court overturns Chevron: what it means for FDA power, drug laws, and public health.
Supreme Court overturns Chevron:...
08/07/2024
First Report Managed Care
Blog
07/31/2024
With 300 active drug shortages, several industry stakeholders have proposed plans to enhance supply chain resilience.
With 300 active drug shortages, several industry stakeholders have proposed plans to enhance supply chain resilience.
With 300 active drug shortages,...
07/31/2024
First Report Managed Care

Advertisement

Blog
07/29/2024
The Centers for Medicare and Medicaid Services recently released final part two guidance on the Medicare Prescription Payment Plan (M3P), formerly known as "smoothing."
The Centers for Medicare and Medicaid Services recently released final part two guidance on the Medicare Prescription Payment Plan (M3P), formerly known as "smoothing."
The Centers for Medicare and...
07/29/2024
First Report Managed Care
Blog
07/24/2024
The M3P offers financial relief by spreading payment throughout the year, and CMS’ latest guidance clarifies key outreach parameters.
The M3P offers financial relief by spreading payment throughout the year, and CMS’ latest guidance clarifies key outreach parameters.
The M3P offers financial relief...
07/24/2024
First Report Managed Care
Blog
07/18/2024
Learn why industry stakeholders should prepare for 2028 negotiations now to ensure long-term financial stability and regulatory compliance.
Learn why industry stakeholders should prepare for 2028 negotiations now to ensure long-term financial stability and regulatory compliance.
Learn why industry stakeholders...
07/18/2024
First Report Managed Care

Advertisement

FY2025
Blog
07/17/2024
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential...
07/17/2024
First Report Managed Care

Advertisement